BPC
ROIV icon

Bryce Point Capital’s Roivant Sciences ROIV Stock Holding History

Bryce Point Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$401K Sell
26,506
-18,022
-40% -$223K 0.49% 134
2025
Q2 		$502K Sell
44,528
-30,739
-41% -$333K 0.42% 139
2025
Q1 		$790K Sell
75,267
-21,283
-22% -$230K 0.59% 96
2024
Q4 		$1.14M Buy
+96,550
New +$1.14M 0.33% 121

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Bryce Point Capital's ROIV Position: Q3 2025 in Review

Bryce Point Capital reduced its Roivant Sciences (ROIV) stake by 40% in Q3 2025, selling an estimated $223K and leaving 26,506 shares worth $401K. The position accounts for 0.49% of the portfolio, ranked #134.

Bryce Point Capital first reported a position in ROIV in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.14M in Q4 2024. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Bryce Point Capital held 26,506 shares of Roivant Sciences worth $401K as of Q3 2025.
  • Bryce Point Capital sold 18,022 Roivant Sciences shares in Q3 2025, an estimated $223K.
  • Roivant Sciences made up 0.49% of Bryce Point Capital's portfolio in Q3 2025, its #134 holding.
  • Bryce Point Capital first reported a position in Roivant Sciences in Q4 2024 and has held it in 4 quarters since.
  • Bryce Point Capital's Roivant Sciences position peaked at $1.14M in Q4 2024.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.